Combined with its expression correlated with tumor grade and clinical stage (Figure 1C&D), DUSP9 was expected to server as a clinical marker molecule in HNSCC to indicate the disease process and assist clinical treatment. The gene discussed is DUSP9; the disease is head and neck squamous cell carcinoma.